Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RV5026B for Erythrocouperosis with Pityriasis Folliculorum
NCT06824870Terminated
- Sponsor
- Pierre Fabre Laboratories
- Start
- Oct 2023
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Erythema score at Day 57, Overall dynamic efficiency score at Day 57 and 8 more. Started Oct 2023; status: terminated.
Beyond the preview
Go deeper on NCT06824870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06824870.